A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger
Launched by WAIKATO HOSPITAL · Nov 16, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study aims to analyse and compare the effectiveness of metacarpophalangeal joint blocking splint versus relative motion extension splint for trigger finger. This will help us find out which one of the two splint designs is more effective in the management of trigger finger, thus improving treatment outcomes for patients with trigger finger.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Trigger finger patient
- Exclusion Criteria:
- • Diabetes, non-English speaking
About Waikato Hospital
Waikato Hospital, a leading healthcare institution in New Zealand, is dedicated to advancing medical research and improving patient care through clinical trials. As a sponsor, Waikato Hospital collaborates with multidisciplinary teams to conduct innovative studies across various therapeutic areas, ensuring adherence to the highest ethical standards and regulatory requirements. With state-of-the-art facilities and a commitment to patient safety, the hospital aims to contribute valuable insights to the medical community while enhancing treatment options for patients. Through its robust clinical trial programs, Waikato Hospital plays a vital role in translating research findings into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Waikato, New Zealand
Patients applied
Trial Officials
Aarti Parekh, B.Physio
Principal Investigator
Waikato Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported